2008, Volume 15, Supplement 1

A symposium, sponsored by CV Therapeutics Europe Ltd, was held during the British Cardiovascular Society (BCS) meeting in Manchester on 2 June 2008. This report...

Reviewing whether chronic stable angina is a benign condition or whether it requires aggressive management, Professor Robert Wilcox (University Hospital, Nottingham) outlined how the subject...

Professor John Camm addressed the role of the late sodium current as a new target in ischaemic heart disease (IHD). The sodium channel itself spans...

“Diabetic patients, despite current therapies, have significant residual risk of cardiovascular events such that we need to think about new agents,” said Professor Mark Kearney...

Professor Adam Timmis (Barts and the London NHS Trust) discussed the thorny issue of inequity in the management of angina, and he started by distinguishing...